chartexchange

STLN
Starling Oncology, Inc. Common Stock
stockNASDAQ

Market OpenNov 19, 2026 9:50:57 AM EST
3.34USD+4.375%(+0.14)303,486
Pre-marketNov 19, 2026 9:29:30 AM EST
3.25USD+1.562%(+0.05)
3.3200Bid3.3400Ask0.0200Spread

STLN Financials

In Q3 FY 2026 (ended ), Starling Oncology, Inc. Common Stock (STLN) reported revenue of $169.77M, net income of −$15.75M, operating cash flow of $10.14M, and assets of $187.77M (filed ).

Loading financial statements…